Cargando…

The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma

OBJECTIVE: The aim of the present study is to determine if CEACAM6 can be detected in the bile of patients with biliary cancer and can serve as a diagnostic biomarker for cholangiocarcinoma. SUMMARY BACKGROUND DATA: Distinguishing bile duct carcinoma from other diagnoses is often difficult using end...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rose, J. Bart, Correa-Gallego, Camilo, Li, Yu, Nelson, James, Alseidi, Adnan, Helton, W. Scott, Allen, Peter J., D’Angelica, Michael I., DeMatteo, Ronald P., Fong, Yuman, Kingham, T. Peter, Kowdley, Kris V., Jarnagin, William R., Rocha, Flavio G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790932/ https://www.ncbi.nlm.nih.gov/pubmed/26974538 http://dx.doi.org/10.1371/journal.pone.0150195

Ejemplares similares

Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy
por: Kingham, T Peter, et al.
Publicado: (2014)

Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma
por: Correa-Gallego, Camilo, et al.
Publicado: (2016)

Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes
por: Sadot, Eran, et al.
Publicado: (2015)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
por: Miller, George, et al.
Publicado: (2009)

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies
por: Johnson, Benny, et al.
Publicado: (2015)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer
por: Ito, Hiromichi, et al.
Publicado: (2013)

Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer
por: Gebauer, Florian, et al.
Publicado: (2014)

Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target
por: Pandey, Ritu, et al.
Publicado: (2019)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 Promotes Carcinogenesis of Gastric Cancer and Anti-CEACAM6 Fluorescent Probe Can Diagnose the Precancerous Lesions
por: An, Fangmei, et al.
Publicado: (2021)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

CEACAM6 Gene Variants in Inflammatory Bowel Disease
por: Glas, Jürgen, et al.
Publicado: (2011)

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing
por: Zheng, Jian, et al.
Publicado: (2018)

Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma
por: Malleo, Giuseppe, et al.
Publicado: (2021)

Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
por: Klaile, Esther, et al.
Publicado: (2017)

On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies
por: Calinescu, Andreea, et al.
Publicado: (2018)

CEACAM family: Carcinoembryonic antigen cell adhesion family, CD66 family, C-CAM family
por: Isacke, Clare M., et al.
Publicado: (2000)

Cell-dependent regulation of vasculogenic mimicry by carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1)
por: Hayashi, Soichiro, et al.
Publicado: (2020)

Acinetobacter baumannii Targets Human Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAMs) for Invasion of Pneumocytes
por: Ambrosi, Cecilia, et al.
Publicado: (2020)

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
por: Winter, Jordan M., et al.
Publicado: (2012)

A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
por: Winter, Jordan M., et al.
Publicado: (2012)

CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness
por: Duxbury, M S, et al.
Publicado: (2004)

CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens
por: Thomas, Jerin, et al.
Publicado: (2023)

Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
por: Sohal, Aalam, et al.
Publicado: (2023)

Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases
por: Evrard, Serge, et al.
Publicado: (2014)

New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
por: Jhaveri, Manan A, et al.
Publicado: (2017)

Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life
por: Sivakumar, Tarika, et al.
Publicado: (2021)

CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
por: Kurlinkus, Benediktas, et al.
Publicado: (2021)

Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival
por: Soares, Kevin C., et al.
Publicado: (2023)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

CEACAM6 promotes cholangiocarcinoma migration and invasion by inducing epithelial-mesenchymal transition through inhibition of the SRC/PI3K/AKT signaling pathway
por: Liu, Chen, et al.
Publicado: (2022)

Isolated Hepatic Splenosis: First Reported Case
por: D'Angelica, Michael, et al.
Publicado: (1998)

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma
por: Ru, Guo-Qing, et al.
Publicado: (2017)

Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells
por: Tian, Chengming, et al.
Publicado: (2020)

Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
por: Burgos, Miguel, et al.
Publicado: (2022)

CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?
por: Racanelli, Alexandra C., et al.
Publicado: (2023)

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma
por: Son, Seung-Myoung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ipa0sev49r36qn16ik3f43il5d